At Stream Bio, we develop and manufacture innovative bioimaging molecular probes, Conjugated Polymer Nanoparticles (CPNs™), for many applications that address longstanding problems within the life science industry. Applications and areas where we can make a significant difference include in vitro and in vivo R&D, diagnostics, lateral flow, IR-imaging and therapeutic R&D.
Invented in the research labs of King’s College London, Stream Bio was founded as the vehicle through which to demonstrate the wide-ranging benefits and applications of CPNs™. Our approach combines a forward-thinking attitude with a breadth of industry expertise in both science and business, enabling us to create CPN™ solutions for the various strands of the life science industry. In the not too distant future, it is expected that Stream’s technology will positively impact in vivo R&D, diagnostics and therapeutics.